pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 19·1 min read
save

Health Tech team hosts consumer health discussions at FT US Pharma and Biotech Summit

May 19, 2026·read at Endpoints ↗Neutral

On Thursday, the Health Tech team led a series of conversations at the Financial Times’ US Pharma and Biotech Summit, an event organized in collaboration with Endpoints News.

The sessions focused on the current state of consumer health, bringing together industry participants to discuss emerging trends and challenges in the sector.

The article is behind a paywall, with limited free access available to readers who sign up for a subscription.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “The state of consumer health”

read at Endpoints ↗
73 words · retrieved May 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 24m agoOrbiMed raises $3B in new life sciences funds, including $1B+ for AsiaEndpoints
  • 1h agoAI will force doctors to focus on clinical reasoning, experts sayEndpoints
  • 3h agoVanda’s social anxiety drug flunks Phase 3 trial in female patientsEndpoints
  • 3h agoPaul Stoffels to bring Galapagos’ cell therapies back to lifeEndpoints
  • 6h agoIambic snags $150M IPO for AI-driven cancer pipelineEndpoints